11/06/2024
5:01 AM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
St George Street Capital (Filed by)
| Form SC 13G/A | |
11/04/2024
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
11/04/2024
4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
11/03/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
11/01/2024
4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEFA14A | |
11/01/2024
3:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEF 14A | |
|
10/28/2024
4:16 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEFA14A | |
10/28/2024
4:17 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form ARS | |
10/24/2024
5:12 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/18/2024
3:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/16/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form PRE 14A | |
10/15/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
5:01 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024
6:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/07/2024
6:38 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:02 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:59 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
| Form SC 13D/A | |
09/19/2024
4:01 PM | Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:41 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
09/16/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
09/06/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
3:44 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/19/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
08/16/2024
3:59 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
4:53 PM | Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:56 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
05/14/2024
3:05 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
04/24/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Intelmed LLC (Reporting)
Lewis-Hall Freda C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Tapolczay David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form NT 10-K | |
02/12/2024
11:51 AM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G/A | |
02/08/2024
12:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
01/10/2024
3:43 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Trump’s Back, but DC’s Coming for Your Money! (Ad) Trump's back in the White House, ready to hit the gas on America's comeback.
He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs.
But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back… Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov |
12/18/2023
3:14 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
12/17/2023
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
12/14/2023
4:16 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Sragovicz Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Tapolczay David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:20 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
McNealey Jennifer Isacoff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:20 PM | Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:50 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1/A | |
12/01/2023
3:52 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2023
7:37 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q/A | |
11/20/2023
4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
